Second segment--Interview with Brady McKellar and Elsa Dimitriades of Wanderlust Theatre about their puppetry in Cody Daigle's adaptation of Neil Gaiman's "Wolves in the Walls" that will open on Thursday July 26th in Burke Hall Theatre (and local events calendar)
A while back, a craze hit my kids' school. It seemed as though everyone in the lunchroom was bringing in those little green packs of seaweed from Trader Joe's — roasted, salted nori, sometimes flavored with wasabi. (Most of these kids like yogurt and olives, too.) Granted, our town has an idiosyncratic population, and many of the parents are health-minded. It was the kids, though, who couldn't get enough of them.
Originally published on Fri July 20, 2012 12:34 pm
"This is our last song." You've probably heard words to that effect any number of times at concerts over the years, but when James Murphy said them on April 2, 2011, from the stage at Madison Square Garden, it was a little different.
This wasn't the last song before the encore. It wasn't the last song of the night, or the last song of the tour. This was to be the last song, period, that Murphy's band — the danceable indie-rock outfit LCD Soundsystem — would play together. Ever.
Originally published on Wed October 17, 2012 10:06 am
The deeper we get into our search for the albums everyone can love, the more intriguing our findings become. For example, last week's poll, shows us that a solid majority of you don't care for the Guns N' Roses album Appetite For Destruction, even though it was a huge record when it first dropped in 1987.
A report (pdf) released today by Human Rights Watch accuses the government of Hugo Chávez in Venezuela of consolidating power in the executive branch and using that power to intimidate his opponents.
"The accumulation of power in the executive, the removal of institutional safeguards, and the erosion of human rights guarantees have given the Chávez government free rein to intimidate, censor, and punish Venezuelans who 'offend' the president or obstruct his political aims," the report found.
Following the FDA approval of Truvada — the once-a-day pill that can drastically lower a person's risk of contracting HIV — Audie Cornish talks with Dr. Wafaa El-Sadr of Columbia University's Mailman School of Public Health. They examine the status of HIV prevention efforts in the U.S. today — what progress has been made and the challenges that still ahead. El-Sadr has worked on HIV/AIDS prevention and treatment since 1981.